Executive Summary: Multiple Chemical Sensitivities State of the Science Symposium

“Multiple chemical sensitivities” has become an increasingly common clinical presentation to physicians, though it is infrequently seen by psychotherapists. This case report describes a 61-year-old woman who presents with a long history of chemical sensitivities, that led to a somatization disorder with debilitating agoraphobia, depression, and marital problems. Features of a variety of anxiety disorders are present, as are metacognitions that required an unusual case conceptualization. A cognitive therapy case conceptualization and treatment are described, which address the highly idiosyncratic clinical presentation of this patient.

Download Full-text

Anxiety Sensitivity and Depression in Multiple Chemical Sensitivities and Asthma

Journal of Occupational and Environmental Medicine ◽

10.1097/00043764-200210000-00006 ◽

2002 ◽

Vol 44 (10) ◽

pp. 890-901 ◽

Cited By ~ 31

Author(s):

Elise Caccappolo-van Vliet ◽

Kathie Kelly-McNeil ◽

Benjamin Natelson ◽

Howard Kipen ◽

Nancy Fiedler

Keyword(s):

Anxiety Sensitivity ◽

Multiple Chemical Sensitivities ◽

Multiple Chemical

Download Full-text

Consensus Recommendations From the Children’s Oncology Group Nursing Discipline’s State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment

Journal of Pediatric Oncology Nursing ◽

10.1177/1043454219854983 ◽

2019 ◽

Vol 36 (4) ◽

pp. 294-299

Author(s):

Janice S. Withycombe ◽

Maureen Haugen ◽

Sue Zupanec ◽

Catherine F. Macpherson ◽

Wendy Landier

Keyword(s):

Clinical Practice ◽

Cancer Treatment ◽

Childhood Cancer ◽

Symptom Assessment ◽

Self Report ◽

Oncology Group ◽

Symptom Trajectories ◽

Science Symposium ◽

State Of The Science ◽

Core Symptoms

Background: Recognizing and addressing illness-related distress has long been a priority for pediatric oncology nurses and the Children’s Oncology Group. Although symptoms are known to be highly prevalent during treatment for childhood cancer, there is currently no guidance for how often symptoms should be assessed, which symptoms should be prioritized for assessment, and how the data should be collected. Methods: The Nursing Discipline, within Children’s Oncology Group, hosted a one-day Interprofessional seminar titled “Symptom Assessment During Childhood Cancer Treatment: State of the Science Symposium.” Following the symposium, an expert panel was assembled to review all available evidence, including information presented and collected during the symposium. Consensus-building discussions were held to identify common themes and to produce recommendations for clinical practice. Results: Four recommendations emerged including (1) the identification of priority “core” symptoms for assessment; (2) inclusion of the child’s voice through self-report, when possible; (3) consistent documentation and communication of symptom assessment results; and (4) implementation of patient/family education related to symptoms. Discussion: Symptom recognition, through appropriate assessment, is the first step in symptom management. The goal for developing and sharing these recommendations is to promote consistent and comparable clinical practice across institutions in regard to symptom assessment during childhood cancer therapy. Integration of these recommendations will set the stage for future studies related to the frequency of symptoms across disease groups, projection of anticipated symptom trajectories, development of evidence-based teaching tools for common symptoms, and evaluation of patient outcomes with enhanced symptom assessment and management.

Download Full-text